Laureen S. Ojalvo
- Immunology top 5%
- Immune cells in cancer 4
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 18
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 4
- Reproductive Medicine top 5%
- Obstetrics and Gynecology top 5%
- Cancer Research top 10%
-
- TGF-β signaling in diseases 16
- Cancer-related gene regulation 7
-
- Cancer Research and Treatments 10
-
- Colorectal and Anal Carcinomas 4
Laureen S. Ojalvo
39 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 75
- Immunology 741
- Oncology 677
- Reproductive Medicine 180
- Obstetrics and Gynecology 132
- Cancer Research 223
Countries citing papers authored by Laureen S. Ojalvo
This map shows the geographic impact of Laureen S. Ojalvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laureen S. Ojalvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laureen S. Ojalvo more than expected).
Fields of papers citing papers by Laureen S. Ojalvo
This network shows the impact of papers produced by Laureen S. Ojalvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laureen S. Ojalvo. The network helps show where Laureen S. Ojalvo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laureen S. Ojalvo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 25 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 18 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 38 | |
| 9 | 2020 | 69 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 5 | |
| 12 | 2019 | 1 | |
| 13 | 2017 | 117 | |
| 14 | 2017 | 38 | |
| 15 | 2017 | 13 | |
| 16 | Emerging immunotherapies in ovarian cancer. | 2015 | 15 |
| 17 | 2013 | 33 | |
| 18 | 2009 | 183 | |
| 19 | 2009 | 178 | |
| 20 | 2009 | 236 |
About Laureen S. Ojalvo
Laureen S. Ojalvo is a scholar working on Biotechnology, Oncology and Immunology, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), TGF-β signaling in diseases (16 papers), Cancer Research and Treatments (10 papers), Cancer-related gene regulation (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Colorectal and Anal Carcinomas (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Immunology (741 citations), Oncology (677 citations) and Reproductive Medicine (180 citations). Laureen S. Ojalvo has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Jeffrey W. Pollard, Charles A. Whittaker, John S. Condeelis, Dianne Cox, W.A. King, Satu Kuokkanen, Lumie Benard, Nanette Santoro, Bo Chen and Leisha A. Emens. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.